Intellectual Property
      FAB Group's Intellectual Property practice focuses on damages analysis, liability,
      valuation, transactions, and other business situations involving our client's product
      and business method patents, copyrights, trademarks, trade secrets and know-how.

      We have experience in major industries including pharmaceutical and biotechnology,
      consumer products and foods, electronics, telecommunications, finance, and automotive.

      We specialize in expert testimony and analysis in complex IP disputes, quantifying economic
      damages and analyzing claims using our depth of courtroom experience and leveraging our
      real-world intellectual asset management and transactional experience.       
    Representative Intellectual Property Engagements

  • New Medium LLC, et al. v. Barco N.V. (Electronics)   
  • Cellularvision v. Alltel Corp. (Video Messaging)   
  • Veeco Instruments v. Asylum Research (Microscope)   
  • Block Financial v. Yodlee (Business Method)   
  • American Stock Exchange v. Mopex, Inc. (Business Method)   
  • Bonzel v. Boston Scientific (Medical Product)   
  • TSE v. Franklynn (Chemical)   
  • Bradford Company v. Jefferson Smurfit (Paper Product)   
  • Ohio Medical Instrument Company v. Johnson & Johnson Professional, Inc. (Medical Product)   
  • Fab-Rite Laminating Corporation v. Standard Textiles Co., Inc. (Textile)   
  • Black & Decker, Inc. v. The Coleman Company, Inc. (Flashlight)   
  • Johnstown America Corporation v. Trinity Industries, Inc. (Railroad)   
  • Tronzo v. Biomet, Inc. (Medical Product)   
  • Univenture v. Case Logic, Inc. (CD Case)   
  • Metaullics v. Molten Metal Equipment, Inc. (Valves)   
  • Flo-Rite v. Wisconsin Pharmacal (Chemical)

    ANDA & Pharma   
  • Astrazeneca AB v. Lek Pharmaceuticals, Impax Laboratories (GERD Drug)   
  • Biovail v. Torpharm (Hypertension Drug)   
  • Aventis v. Apotex (Antidiuretic Replacement)   
  • Novartis v. Apotex (Osteoporosis Drug)   
  • Sanofi-Synthelabo, et al. v. Apotex (Anti-Platelet Drug)   
  • Apotex v. Merck (Hypertension Drug)   
  • E.I. du Pont de Nemours v. Abbott Laboratories (Asthmatic Drug)

    Copyright & Trademark   
  • National Tobacco Co. v. Republic Tobacco Co. (Trademark)   
  • York Wallcoverings v. S.A. Maxwell (Copyright)   
  • Heirs of Uno v. Mattel (Copyright)   
  • United National Bank v. United National Bank (Trademark)   
  • Jeffrey Industries v. Fox Broadcasting (Trademark)   
  • Northern Instruments, Inc. v. Sealed Air, Inc. (Trademark)

    Trade Secret & Unfair Competition   
  • AB Goteneds Mekaniska Verkstad v. Roper Whitney (Machinery)   
  • Heartbilt Homes v. Stuart Shelton (Log Homes)   
  • Zimmer Great Lakes, Inc. v. Biomet, Inc. (Medical Products)   
  • MonoSol, LLC v. Aquafilm, Ltd. (Industrial Products)   
  • Van Kampen American Capital v. SMP II Limited Partnership (Real Estate Development)   
  • Van Dorn/Central States v. Phoenix (Metal Cans)   
  • Great Lakes Dredge & Dock v. Former Employee (Dredging)   
  • Colonial Guild v. Matthews (Interment)   
  • Metaullics v. Molten Metal Equipment, Inc. (Valves)

  • Hill's Pet Nutrition v. Nutro (Lanham Act - False Advertising)   
  • KLS-Martin v. Biomet, Inc. (Anti-Trust )   
  • Medalist Industries, Inc. v. Windsor Knitting Mills, Inc. (Royalty Analysis)   
  • Foreign Manufacturer v. Kayser-Threde (Royalty Analysis)   
  • BASF v. Old World Trading Co. & Dearborn Co. (W.R. Grace) (Lanham Act - False Advertising)

Intellectual Property: Featured Cases

    Black & Decker, Inc. v. The Coleman Company, Inc. (Flashlight)
    ...Developed lost profits and reasonable royalty arguments for Black & Decker, related to one of its hottest new inventions, "Snakelight," a flexible flashlight.
    Result: Favorable settlement

    Tronzo v. Biomet, Inc. (Medical Product)
    ...Developed reasonable royalty arguments for Dr. Tronzo in connection with a novel and widely accepted hip replacement feature.
    Result: Favorable settlement following jury award for $55 Million

    Novartis v. Apotex (Osteoporosis Drug)
    ...Developed patent invalidity arguments based on secondary factors of non-obviousness in connection with the accelerated new drug application "ANDA" for a generic osteoporosis drug.
    Result: Favorable settlement; Generic market entry

    Heirs of Uno v. Mattel (Copyright)
    ...Developed disgorgement of profits and reasonable royalty arguments for the heirs of the creator of the Uno card game in connection with breach of licensing and copyright infringement claims.
    Result: Favorable settlement